HUTCHMED (China) Ltd

Research HUTCHMED (China) Ltd (HCM) on Bullrun: market cap USD 1.84B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHCM
• ExchangeNASDAQ
• CountryHong Kong
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 1.84B
• Financial periodFY2025
• RevenueUSD 548.51M
• Revenue growth-13.0%
• Net incomeUSD 456.91M
• Free cash flow-USD 78.81M
• Gross margin38.7%

Valuation Snapshot

latest market cap is USD 1.84B.

About HUTCHMED (China) Ltd

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Frequently asked questions

What is HUTCHMED (China) Ltd's market cap?

HUTCHMED (China) Ltd's market capitalization is USD 1.84B.

What does HUTCHMED (China) Ltd do?

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.